A new study conducted by researchers from the University of Melbourne suggests that a ‘megadose’ of a salt made from vitamin C may have the potential to reverse the extensive harm sepsis can cause in the brain. Sepsis, a life-threatening condition triggered by the body’s overreaction to an infection, can lead to organ damage, cognitive impairment, disability, and in severe cases, prove fatal.
The study involved testing the effects of sodium ascorbate, a salt of vitamin C, on sheep that were induced with sepsis. The results of the experiment were remarkable, with researchers reporting a dramatic response to treatment after administering the megadose of sodium ascorbate to the animal models. Cardiovascular physiologist Clive May expressed astonishment at the significant changes observed in the animals following the treatment.
Sepsis has a particularly detrimental effect on the brain’s frontal cortex, which controls body movements, speech, and emotional expression. The condition leads to decreased oxygen levels and blood flow in this region, resulting in elevated local temperatures and potential cognitive difficulties, delirium, and coma. The team’s analysis indicated that sodium ascorbate could reverse these damaging trends and improve brain function.
While the exact biological mechanisms behind the positive effects of sodium ascorbate are not yet fully understood, the study revealed an increase in plasma vitamin C levels and the significant effectiveness of the treatment. Vitamin C is recognized for its anti-inflammatory properties and its role in regulating the immune system, which likely contributes to its impact on sepsis-induced brain damage.
The researchers are now focused on determining whether the same benefits observed in sheep can be replicated in human subjects. Additionally, they aim to establish a safe and effective dosage of sodium ascorbate that can deliver therapeutic benefits without causing adverse effects. Previous clinical trials investigating the use of vitamin C in sepsis treatment have yielded mixed results, but this recent study offers promising prospects for developing a universally effective therapy.
A small-scale clinical trial involving sodium ascorbate as a sepsis treatment has been completed, with ongoing research phases planned. Neuroscientist Yugeesh Lankadeva highlighted the positive effects of sodium ascorbate on the kidneys and cardiovascular system of septic patients in previous studies. The promising results of this research indicate that vitamin C may hold significant potential in reversing sepsis-induced brain damage and improving patient outcomes.
Leave a Reply